Search Results Search Sort by RelevanceMost Recent AMA Code Says Jul 2017 AMA Code of Medical Ethics’ Opinions on Patient Decision-Making Capacity and Competence and Surrogate Decision Making Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics' opinions related to decision-making capacity and competence and surrogate decision making. AMA J Ethics. 2017;19(7):675-677. doi: 10.1001/journalofethics.2017.19.7.coet1-1707. Policy Forum Feb 2022 Por qué los enfoques no carcelarios basados en la atención para las personas detenidas con enfermedades mentales son clave para volver a confiar o no en los profesionales o la autoridad estatal Frederic G. Reamer, PhD AMA J Ethics. 2022;E145-149. doi: 10.1001/amajethics.2022.145. Policy Forum Feb 2022 Why Care-Based, Not Carceral, Approaches to Suspects With Mental Illness Is Key to Whether We Trust Professional or State Authority Ever Again Frederic G. Reamer, PhD Police, prosecutors, defense attorneys, judges, and parole boards look to reform work with patients. AMA J Ethics. 2022;24(2):E145-149. doi: 10.1001/amajethics.2022.145. Podcast Feb 2022 Author Interview: “Why Care-Based, Not Carceral, Approaches to Suspects With Mental Illness Is Key to Whether We Trust Professional or State Authority Ever Again” Dr Frederic G. Reamer joins Ethics Talk to discuss his article: “Why Care-Based, Not Carceral, Approaches to Suspects With Mental Illness Is Key to Whether We Trust Professional or State Authority Ever Again” Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Jun 2003 Diagnosis: Inadequate Cross-Cultural Communication Anne R. Su Virtual Mentor. 2003;5(6):205-207. doi: 10.1001/virtualmentor.2003.5.6.ccas2-0306. Medical Education Oct 2003 Stigma, Society, and Specialty Choice: What's Going On? Sam Huber Virtual Mentor. 2003;5(10):436-439. doi: 10.1001/virtualmentor.2003.5.10.medu1-0310. Health Law Oct 2003 In Defense of Exceptions to Confidentiality Dudley Stewart, MD Virtual Mentor. 2003;5(10):445-448. doi: 10.1001/virtualmentor.2003.5.10.hlaw1-0310. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
AMA Code Says Jul 2017 AMA Code of Medical Ethics’ Opinions on Patient Decision-Making Capacity and Competence and Surrogate Decision Making Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics' opinions related to decision-making capacity and competence and surrogate decision making. AMA J Ethics. 2017;19(7):675-677. doi: 10.1001/journalofethics.2017.19.7.coet1-1707.
Policy Forum Feb 2022 Por qué los enfoques no carcelarios basados en la atención para las personas detenidas con enfermedades mentales son clave para volver a confiar o no en los profesionales o la autoridad estatal Frederic G. Reamer, PhD AMA J Ethics. 2022;E145-149. doi: 10.1001/amajethics.2022.145.
Policy Forum Feb 2022 Why Care-Based, Not Carceral, Approaches to Suspects With Mental Illness Is Key to Whether We Trust Professional or State Authority Ever Again Frederic G. Reamer, PhD Police, prosecutors, defense attorneys, judges, and parole boards look to reform work with patients. AMA J Ethics. 2022;24(2):E145-149. doi: 10.1001/amajethics.2022.145.
Podcast Feb 2022 Author Interview: “Why Care-Based, Not Carceral, Approaches to Suspects With Mental Illness Is Key to Whether We Trust Professional or State Authority Ever Again” Dr Frederic G. Reamer joins Ethics Talk to discuss his article: “Why Care-Based, Not Carceral, Approaches to Suspects With Mental Illness Is Key to Whether We Trust Professional or State Authority Ever Again”
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Jun 2003 Diagnosis: Inadequate Cross-Cultural Communication Anne R. Su Virtual Mentor. 2003;5(6):205-207. doi: 10.1001/virtualmentor.2003.5.6.ccas2-0306.
Medical Education Oct 2003 Stigma, Society, and Specialty Choice: What's Going On? Sam Huber Virtual Mentor. 2003;5(10):436-439. doi: 10.1001/virtualmentor.2003.5.10.medu1-0310.
Health Law Oct 2003 In Defense of Exceptions to Confidentiality Dudley Stewart, MD Virtual Mentor. 2003;5(10):445-448. doi: 10.1001/virtualmentor.2003.5.10.hlaw1-0310.